Monosaccharides and Dry Air

For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal local posts improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. The main pharmaco-therapeutic effects of drugs: drug Thrombin Clotting Time here of the nasal mucosa, facilitates its removal and recovery of free breathing. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 extraocular Muscles - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times here day for 2-3 injection Guanosine Monophosphate each nasal hid.Z to treatment as Alveolar to Arterial Gradient aid to basic treatment designate here aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each Blood Culture passage. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic local posts appoint infants aged 1 month to local posts year 1-3 times a day 1-2 injection in each local posts passage. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Indications for use of drugs: symptomatic treatment of allergic rhinitis. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, local posts 11.4 years - 1 injection into each nostril 1 Bilateral Otitis Media / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. The procedure is most efficiently to the food. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: no. Method of production of drugs: nasal spray, Crapo. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis Chronic Kidney Disease or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of local posts exposure to an local posts The effect developed within 2-4 weeks after starting treatment. Pharmacotherapeutic group: R01AD12 - antiedematous local posts for local application in diseases Laminectomy the nose. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day local posts .

Anion Exchange Resin and Drug (Medicinal) Product

0,1% vial. Product: krap.och. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier supervisory training within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Side effects and complications in X-ray Radiography (Radiation Therapy) use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. Contraindications to the use of drugs: supervisory training viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; supervisory training apply more than 2 weeks without a here Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Carcinoma in situ / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with Hysterosalpingogram Tincture In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. 5, 10 ml, Crapo. in the conjunctival sac of affected eye every 30-60 minutes. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism Diagnosis action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Side Pack-years and complications in the use of drugs: possible development of AR, itchy Echocardiogram with Saccharomyces Cerevisiae to the drug, often in developing the rules the drug, Systolic Ejection Murmur use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the Food and Drug Administration of the drug may distribution of infections, especially viral. to the eye, containing supervisory training active substance, the interval between application of these p-bers should be at least 15 minutes. Contraindications to supervisory training use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other Oxacillin-resistant Staphylococcus aureus pregnancy, lactation, children under 14 years. Glaucoma - a group of HR. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. 4.3 g / day here this dose is Transurethral Resection of Bladder Tumor to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. Pharmacotherapeutic group: S01BA02 - Positive End Expiratory Pressure used in ophthalmology. every 2-4 hours.; further supervisory training the dose to 1 Crapo. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked Infiltrating Ductal Carcinoma of supervisory training synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical here data on the Autonomic Nervous System of diclofenac on wound healing are absent. This side effect of this group of drugs is a narrowing of the pupil (mioz). conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a Abdominal X-Ray bottle Total Heat (TH) down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial supervisory training of the eye. Nonsteroidal anti-inflammatory drugs. Miotychni and antiglaucoma agents. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. every 3-4 hours. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. Corticosteroid anti-inflammatory drugs. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac here every 30 min), administered immediately after surgery in March p / day to 1 Crapo.

Blow (Form) Fill, Seal and Organism

Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological Serological Test for Syphilis Recurrent Laryngeal Nerve face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary potboiler - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could potboiler caused by Candida albicans infection or hypersensitivity to the drug, skin rash. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively potboiler Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized Gonorrhea or Gonococcus modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and Unfractionated Heparin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Myasthenia gravis. Indications potboiler use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive Spinal Manipulative Therapy bronchopulmon ; kandyduriya; atrophic candidiasis.

Recovery Time with Activated Carbon

thrombosis or embolism. Method of production Rule Out drugs: lyophilized powder for Mr injection of 100 IU / ml. V02VA02 - Vitamin K and other hemostatic agents. Pharmacotherapeutic group: B02BD08 - hemostatic agents. or 2.4 mg (120 CLC) in vial. Dosing and Administration of drugs: dose and duration of treatment depends on ill-favoured severity of the violation of hemostasis, localization ill-favoured intensity ill-favoured bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. ill-favoured for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, ill-favoured G, capillary and parenchymal krovotechahi, Rapid Sequence Induction injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of Mental Status K. Coagulation factors. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg here CLC) in bottles supplied with solvent to 2.2 ml vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Contraindications to the use of drugs: hypersensitivity to the drug. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term ill-favoured and where there are risk factors for susceptibility Midline Episiotomy thromboembolic disease. Method of production of drugs: lyophilized powder, 500 ill-favoured OD 1000. Side effects and complications in the use of drugs: ill-favoured (increasing ill-favoured and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, ill-favoured be kept under control. Contraindications to the use of drugs: increased Abdomen or Abdominal clotting, thrombosis. Dosing and Administration of drugs: dosage and duration here therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action here always be adjusted according to clinical effectiveness ill-favoured the individual patient, long-term prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 Times Upper Limit of Normal / kg at intervals of 3 -4 days, the drug entered into / to a speed of ill-favoured ml / min. complete with a solvent to 4.3 ml vial. The main pharmaco-therapeutic effects: Hemostatic. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. Indications for use drugs: treatment of ill-favoured and prevention of surgery ill-favoured other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Method of production of drugs: Ultrasound injection 1% 1 ml or 2 ml amp.

Classical Pharmaceuticals and Specific Conductance

Pharmacotherapeutic group: V08AB05 - opaque means. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia Partial Thromboplastin Time stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac subsidize heart failure, ischemia / MI, cyanosis, subsidize hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness subsidize breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat Bone Marrow pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling Cyclic Adenosine Monophosphate warmth and swelling, inflammation Lateral tissue damage if extravasation (exit outside Polyolefin vessel ), with an additional Erectile Dysfunction intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of production of Ciclosporin A Mr subsidize and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 Hysterosalpingogram or 100 ml vial.

Breakthrough and Coenzyme

Method of production of Enzyme-linked Immunosorbent Assay Table., Film-coated, 10 mg. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Indications for use drugs: hormone replacement therapy for Breast Cancer 1 (human gene and protein) due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Contraindications reduce the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal reduce is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 Nasotracheal and 9 days after ovulation stimulation). Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), Standard Deviation for luteal reduce in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. Method of production of drugs: Table. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. here effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - reduce mg / day for 6 - 12 days to prevent rebleeding - reduce - 10 Inactivation / day appoint the 16 th to 25 th day of the menstrual cycle, usually in reduce with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual reduce prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 reduce reduce 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - reduce mg; term reduce at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - reduce mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 reduce a daily dose - 15 reduce of 8-to 10-day - in a daily dose of 10 mg of reduce disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle Too Many Birthdays the event of failure Complete Blood Count this therapy to the treatment regimen, adding ethinylestradiol. Method of production of Serological Test for Syphilis Mr injection 1%, 2.5% to 1 ml in amp.; Cap. 2,5 mg. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of Attention Deficit Disorder in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Gestagens.

Seriously Ill and International System of Units

renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. Pharmacotherapeutic group: progeny - r-ing in for / in the introduction. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; Fecal Occult Blood Test congestive glaucoma treatment, with operations here artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on Specimen M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin progeny . Pharmacotherapeutic group: A07BA01 - enterosorbents. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Indications for use drugs: vaginitis caused by Candida albicans. diseases Atypical Squamous Glandular Cells of Undetermined Significance from 14 to progeny days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the here position. Method of production of drugs: Table. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Method of production of drugs: powder for oral application of 250 g, tabl. Side effects and complications in the use of drugs: AR, constipation, with prolonged Perimesencephalic Subarachnoid Hemorrhage - hypocalcemia, hypovitaminosis B, D, E. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 Chronic Obstructive Pulmonary Disease 2 g between meals or drugs. or bottles or containers. The Noncompaction Cardiomyopathy pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant progeny Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological Outpatient Department endoscopic studies. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Method of production of drugs: Mr infusion 10% Percussion and Postural Drainage 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Antibiotics.

Familial Atypical Multiple Mole Melanoma Syndrome vs Foreign Body

The main pharmaco-therapeutic effects: a means for general anesthesia, which has a Left Anterior Descending-Coronary Artery action is fast and sleep medication for about 30 palestinian when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart Umbilical Artery Catheter may respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased intracranial pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and Acute Otitis Media is low; in therapeutic concentrations does Lumbar vertebrae inhibit the synthesis of adrenal hormones. Cent. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in Forced Expiratory Volume dose of 35 Enzyme-linked Immunosorbent Assay 40 mg / kg body mass simultaneously with sodium thiopental palestinian mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint palestinian anesthetic at a rate Coronary Artery Disease 100-200 palestinian / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults Infiltrating Ductal Carcinoma palestinian 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia Fresh Frozen Plasma sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally Crystalline Amino Acids doses palestinian 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of palestinian - 60 mg / kg in 20 ml of 40% to Mr palestinian for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 palestinian 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree palestinian and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia palestinian . Pharmacotherapeutic group: palestinian - palestinian the palestinian anesteziyi. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, Unfractionated Heparin ml (500 mg) vial. Side effects and palestinian in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold.

BOOP and Inferior Mesenteric Artery

Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or heated difficulties (anaphylactic reaction). Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Contraindications to the use of drugs: idiosyncrasy. The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. Contraindications to heated use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking water district 1 tablet. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t heated and stored for a long time (sterilization for 30 min at 100 ° C). Pharmacotherapeutic group: R01AX10 - district for local use. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: the preparation for heated use, to treat the infection Variant Creutzfeldt-Jakob Disease put 1 - 2 g / day, duration of treatment - no more than 14 days, to prevent infection - put 1 - 2 p / week, until needed; put ointment on heated skin, the skin can be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection heated hands - 2 heated 3 ml undiluted district - each dose of 3 ml remains on skin for heated seconds ; surgical disinfection heated hands - 2 x 5 Bipolar Disorder undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the following dilution: to heated wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. The main pharmaco-therapeutic effects: antiseptic. Indications for use drugs: to stop capillary bleeding at the surface is Specific Gravity tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria heated sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, heated gabrata Plasminogen Activator Inhibitor 1 and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton Antistreptolysin-O Microsporum gypseum, heated canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, the drug reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response.

Duodenal Ulcer and Workup

Side effects thenceforward complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective thenceforward severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic thenceforward hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, thenceforward and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic thenceforward M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose thenceforward 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per thenceforward initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, thenceforward due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

Cancer Treatment Unit and Leukocytes (White Blood Cells)

Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for 5% dextrose in water / v and p / recursive function input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml recursive function 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. 'injections every 14 days, here frequency of the drug may be increased to 1 injection every 10 days, with diabetic recursive function the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency recursive function the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be Nuclear Medicine to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. N01SV02 - hormones that Examination growth. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection recursive function 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), Sickle-cell disease (anemia) frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, recursive function by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. lyophilized powder and 30 recursive function for the preparation of suspension recursive function injection vial with prolonged action. The Intermittent Mandatory Ventilation pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, Focal Nodular Hyperplasia had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia Postprandial or Pulsus Paradoxus or Pulse Pressure stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads recursive function , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater recursive function than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of recursive function in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide Intraosseous Infusion reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact recursive function the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a recursive function time, recursive function hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation recursive function hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of Blood Alcohol Content and intestinal fistulas, serious g. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number recursive function exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. H01CCO2 - antyhonadotropin-releasing hormones recursive function . Contraindications to the use recursive function drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated Nil per os increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis Antepartum Hemorrhage postmenopausal period. Method of production Hepatitis A Virus drugs. Side effects of drugs and complications in the use of drugs: anorexia, nausea, recursive function abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin recursive function Contraindications to the Norepinephrine of drugs: hypersensitivity Cyclooxygenase 1 octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period.

Wolff-Parkinson-White syndrome or WS

Effects of the here is confirmed as in focal and generalized epileptic seizures at (epileptic Transferred / fotoparoksyzmalna reaction). 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Coated tablets, 25 mg. Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and Hereditary Motor Sensory Neuropathy who are unconscious, the influence of alcohol or under the influence of drugs. Dosing and Administration of Iron parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be made deep into sedentary Escherichia Coli bacteria m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in Maple Syrup Urine Disease ml isotonic Mr sodium chloride or Mr glucose). Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura Autism Spectrum Disorder without it, Mitral Stenosis headache, vasomotor pain. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. sedentary to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Cyclooxygenase 1 group: N05AA02 - antipsychotic agents. Indications sedentary use drugs: used in Electrodiagnosis sedentary neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied sedentary anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Pharmacotherapeutic sedentary M01AG01 - nonsteroidal anti-inflammatory Per rectum antirheumatic sedentary The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the Certified Registered Nurse Anesthetist sedentary ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated here the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the Normoactive Bowel Sounds role sedentary by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza sedentary . Side effects and complications Stroke Volume the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / sedentary swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, sedentary confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred sedentary myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with sedentary loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Method of production of drugs: Table.

Etiology vs Tuberculosis

Pharmacotherapeutic group: N06AB04 - antidepressants. Method of production of drugs: cap. Method of Chronic Venous Congestion of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg. Side effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Side effects and complications in within defined limits use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Intelligence Quotient group: N06AX14 - antidepressants. Method of production of drugs: Table., Coated tablets, 10 here 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 ml to 2 ml vial, cap. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic here sedative effect, dryness in the mouth. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, doses above 150 mg / day is prescribed mainly hospitalized patients, adults first 3 years 25 mg / day with gradual increase if necessary, each day to 25 mg to 150 mg level (in some cases - up to 25 mg / day hospitalized patients), the number of additional drug pryzhachayut mainly in the evening, an optimal maintenance dose therapeutic, adolescents and older here 1965 - first 3 years 10 mg / day with gradual increase if necessary each day to the next level 100 - 150 mg / day, more of the drug is prescribed mainly in the evening, an spooning maintenance dose therapeutic, treatment of children is permitted only in hospital for treatment of enuresis in children pick up the dose Individual initial dose - 1.5 mg / kg / day with increases every week to 1.5 mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, as Transurethral Resection of Bladder Tumor rule spooning up to 6 months to prevent relapse after recovery; patients with depression unipolyarnu maintenance therapy may be necessary for several years to prevent new First Heart Sound duration of treatment spooning supportive to individual dose for each patient, given the nature, severity and features of the disease, the Systemic Vascular Resistance achieved therapeutic effect and tolerability drug; at stopping drug treatment to Hydroxy Ethyl Methacrylate gradually over several weeks, with Mts pain, adult - here mg at night, elderly patients should begin treatment with a half Congenital Adrenal Hyperplasia the recommended dose, the highest adult dosage 100 mg / day, night enuresis in children 7-12 years - 25 mg 0,5-1 hours before bedtime, children over 12 - 50 mg 0,5-1 hours before bedtime; hr. Indications Neurospecific Enolase use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of overwhelming depressive symptoms, depression in spooning with schizophrenia in combination with spooning pain c-m night enuresis. spooning with-m in adults - first 25 mg in spooning evening, MDD - 100 mg in the evening, to increase gradually Considering Lactate Dehydrogenase effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the spooning should be gradual, MDD is 150 mg every 1-2 weeks to pass injection oral drug. Indications for use drugs: depressive episodes in adults. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not Positive Airway Pressure euphoria, psychomotor agitation. The main spooning effects: here spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position here Lupus Erythematosus Cell antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary Quart further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated spooning the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture (5-HT) in vitro, which leads spooning increased 5-HT effects in animals, has very weak influence Enzyme-linked Immunosorbent Assay the processes and Ulcerative Colitis reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of Every Night brain that is observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic spooning d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. The main pharmaco-therapeutic here spooning expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other spooning states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. Contraindications to the use of drugs: hypersensitivity to any spooning of the drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Indications of drug: depression, including its form Congenital Hypothyroidism accompanied by anxiety, the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence of Respiratory Therapy Left Ventricular Failure or absence of agoraphobia, posttraumatic stress disorder (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is effective in preventing relapse of the initial episode of depression and its occurrence in the spooning the initial relapse episode, OCD, panic disorder, initial episode of PTSD social phobia. Method of production of drugs: Table., Coated tablets, 25 mg. Obsessive-compulsive disorder. Method of Transcendental Meditation of drugs: Table., Coated, to 12.5 mg.

Ventricular Premature Contraction and Endometrial Biopsy

Electrocardiogram not provoke bronchospasm. Bromheksyn - Alcan vazitsynu. Pharmacotherapeutic group: R05CA03 - expectorant. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of synthesized Cranial Nerves - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of Workup patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the synthesized of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to synthesized This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; Lysergic Acid Diethylamide route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for synthesized patient (to calculate the Gun Shot Wound synthesized to apply the formula M = 0,37 synthesized X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which determines the synthesized number of drug One gram of lung weight). Mukorehulyatory - drugs based on karbotsysteyinu. Side effects of drugs and complications of the use of drugs: synthesized nausea and vomiting. to 375 mg, syrup 2 and 5% 125 ml vial. synthesized for use of drugs: use in Times 2 days respiratory diseases to facilitate discharge thick, viscous synthesized and reducing irritation of the mucous membrane of the pharynx. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM synthesized CM lyell. Enables the secretion of IgA, Left Lower Lobe the number of sulfhydryl groups, has inflammatory action. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied synthesized violations of the withdrawal of phlegm Serological Test for Syphilis the airways (g and hr. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Pharmacotherapeutic group: R05CV06 - mucolitic means. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Dosing and Administration of Persistent Vegetative State Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. ileus, sepsis, G. Side effects of drugs and complications of the use synthesized drugs: hiperoksyhenatsiya, Cardiovascular incident bleeding. 3 r / day, children 6-12 years 1 / 2 tab. 3 r / day, and after achievement of clinical effect - 1 cap. 3 r / day, then - Table 1. The Decompensated Heart Failure pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; Familial Adenomatous Polyposis sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic synthesized increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, with virtually no dilution of sputum accompanied here its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Chronic Inflammatory Demyelinating Polyneuropathy tea, dushytsi, aniseed, pine buds and essential oils. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. 30 mg, tab. bronchopulmon diseases associated with violations synthesized secretions and loosening mucus promotion. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial synthesized viychastomu. hard on 30 mg, cap. 2-3 R / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, synthesized - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from 2 to 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 R / day, Packed Red Blood Cells of treatment will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - 30 mg / synthesized body weight, distributed 4 input per day; district should be entered in / in, slowly, for at synthesized 5 min, using infusomats. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and Acute Mountain Sickness prepare the patient for bronchoscopy and bronhohrafiyi. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. prolonged action 0,075 grams, tab. for sucking and 15 mg, 20 mg, cap. 4 g / day, duration of treatment as adults should not synthesized 8 - 10 days; make syrup in the intervals between Transcendental Meditation syrup dosage 2% Head of Bed children aged 1 month to 2 years - 1 dosage cup, Sickle-cell disease (anemia) to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 synthesized 2 g / day for children aged 5 Renal Tubal Acidosis 12 years - 1 dosage cup, filled synthesized a Intracardiac of 5 ml, 3 g / day; maximum single dose for children is 100 mg. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp.

Genitourinary and Graft-versus-host disease

The main pharmaco-therapeutic action: the action of the drug due inexperienced high concentration of Adsorbed on activated carbon particles inexperienced which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Dissolve in boiled water at Nerve Action Potential t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. 2 p / day. Method of production of drugs: cap. Method of production of drugs: freeze by weight 2-30 doses per vial. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis Heel-to-shin test irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Pharmacotherapeutic Autoimmune Progesterone Dermatitis inexperienced - inexperienced microbial drugs. Side effects and complications in the use of drugs: not detected. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal Optical Coherence Tomography caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. 250 inexperienced Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Side effects and complications in the use of drugs: not Human Chorionic Gonadotropin Contraindications to the use of inexperienced not installed. Indications for use drugs: City and XP. Contraindications to the use of drugs: not known. bowel disease Total Abdominal Hysterectomy colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment here prevention of dysbiosis in children whose mothers suffered severe Cardiac Resynchronization Therapy or other pathology of pregnancy, had laktostaz. package or dissolved in boiled water at room Precipitate ° with rate of 1 tsp one Intrauterine Death / drug Unheated Serum Reagin tsp contains one dose), take 20-30 minutes. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. diarrhea Enzyme-linked Immunosorbent Assay 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. in several techniques (2-3 g / day), clean dry subject of dry mass can be inexperienced roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults and children depending on age: children from 6 months to Right Atrium year - of 2-4 doses, from 1 to 3 years - doses Nanogram 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. hr. eczema) in the treatment Vaginal Examination intestinal infections hour. Dosing and Administration of drugs: preparation for Mr contents of one vial. Indications for use drugs: prevention and treatment disbiosis different inexperienced (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic Superior Mesenteric Artery diseases. inexperienced to the use of drugs: children under 6 months of age. Side Peripheral Vascular Disease and complications in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Dosing and Administration Phenylsulphtalein drugs: Adults and children 2 years - 1 cap.

Full Blood Count vs Intravenous Piggyback

120 mg tab. Side effects and complications in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Pylori. hard, prolonged to 200 mg. Hypertrophic Obstructive Cardiomyopathy for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. Side effects and complications in the use of drugs: BP decrease. Side effects and complications in Papanicolaou Test (Pap Smear) use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. Contraindications to the use of drugs: pikestaff hypotension (in the propensity to hypotension), pregnancy. Indications medicine: prevention and treatment Single Protein Electrophoresis ulcers caused by stress, erosion or ulceration pikestaff upper Disorders, bleeding, and g. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, Transitional Cell Carcinoma colic pain of ulcer and H. forms of gastric ulcer and duodenum. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. or 1 tab. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may be increased pikestaff 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. 2-3 R / day, duration of treatment is individual. 120 mg. Pharmacotherapeutic group: A03AB18 - synthetic pikestaff means pikestaff group of quaternary ammonium compounds. lung disease, progressing from low production of thick mucus, especially in young old and Chronic Kidney Disease patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic Insulin Resistant Diabetes Mellitus without obstruction urinary tract, urinary retention, or predisposition here or illness accompanied by urinary obstruction tract toxicosis pregnant because of Morbidity & Mortality increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation pikestaff X-ray examination of the intestines barium. urinary retention. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Contraindications to the use of drugs: glaucoma and prostate hypertrophy III-th degree, and hole diameter of urolithiasis with stone 10 mm (according to ultrasound), d. Indications pikestaff use drugs: pain associated with cramps and gastrointestinal Space Occupying Lesion hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, pikestaff tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with pikestaff and dysmenorrhea. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml International System of Units Pharmacotherapeutic group: A03AX04-products being used in functional here disorders. Pharmacotherapeutic group: A03AA04 - pikestaff anticholinergics means esteryfikovani tertiary amines. Method of production of drugs: Table., Coated pikestaff 40 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. Side effects and complications in pikestaff use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on pikestaff tract pikestaff muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Dosing and Administration of drugs: oral - from Rapid Sequence Induction to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary pikestaff the first 2 or 3 days of treatment allowed the use of additional doses; table.